» Articles » PMID: 39934390

Association Between Neutrophil Percentage to Albumin Ratio and Short Term Prognosis of Acute on Chronic Liver Failure Treated with Artificial Liver Support System

Overview
Journal Sci Rep
Specialty Science
Date 2025 Feb 11
PMID 39934390
Authors
Affiliations
Soon will be listed here.
Abstract

The impact of neutrophil percentage-to-albumin ratio (NPAR) on the outcome of acute-on-chronic liver failure (ACLF) is scant. A retrospective cohort study was conducted in patients with ACLF treated with artificial liver support system (ALSS). The ACLF was diagnosed according to the Chinese Group on the Study of Severe Hepatitis B-ACLF (COSSH ACLF) criteria. Disease severity was rated according to the COSSH ACLF score. Restricted cubic splines, linear or Cox regression models were used to investigate the relationships of baseline NPAR with disease severity and 90-day prognosis. The 90-day transplant-free and overall survival rates of 258 eligible patients were 58.5% and 66.3%, respectively. The NPAR in transplant-free survivors was lower than that in transplant or death patients (22.8 ± 4.4 vs. 25.3 ± 3.7, P < 0.001). NPAR was positively associated with COSSH ACLF score (adjusted β (95% CI) > 0, P < 0.001), transplant-free survival (adjusted HR (95% CI) for transplant or death: 1.07 (1.02-1.13), P = 0.007), and overall survival (adjusted HR (95% CI) for death: 1.09 (1.03-1.15), P = 0.003). Patients with NPAR ≥ 22.4 had poor 90-day prognosis compared to the rest (all adjusted HR (95% CI) > 1, P < 0.05). NPAR was positively associated with disease severity and poor short-term prognosis in patients with COSSH ACLF who underwent ALSS treatment. Thus, it could be used as a prognostic biomarker for COSSH ACLF.

References
1.
Choudhury A, Jindal A, Maiwall R, Sharma M, Sharma B, Pamecha V . Liver failure determines the outcome in patients of acute-on-chronic liver failure (ACLF): comparison of APASL ACLF research consortium (AARC) and CLIF-SOFA models. Hepatol Int. 2017; 11(5):461-471. DOI: 10.1007/s12072-017-9816-z. View

2.
Ko C, Fang K, Tsai M, Lee Y, Lai C, Hsu C . Prognostic Value of Neutrophil Percentage-to-Albumin Ratio in Patients with Oral Cavity Cancer. Cancers (Basel). 2022; 14(19). PMC: 9564168. DOI: 10.3390/cancers14194892. View

3.
Liu Z, Dong L, Shen G, Sun Y, Liu Y, Mei J . Associations of neutrophil-percentage-to-albumin ratio level with all-cause mortality and cardiovascular disease-cause mortality among patients with hypertension: evidence from NHANES 1999-2010. Front Cardiovasc Med. 2024; 11:1397422. PMC: 11288876. DOI: 10.3389/fcvm.2024.1397422. View

4.
Heybe M, Mehta K . Role of albumin infusion in cirrhosis-associated complications. Clin Exp Med. 2024; 24(1):58. PMC: 10980629. DOI: 10.1007/s10238-024-01315-1. View

5.
Kim W, Mannalithara A, Heimbach J, Kamath P, Asrani S, Biggins S . MELD 3.0: The Model for End-Stage Liver Disease Updated for the Modern Era. Gastroenterology. 2021; 161(6):1887-1895.e4. PMC: 8608337. DOI: 10.1053/j.gastro.2021.08.050. View